Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines

Narendra Wajapeyee(University of Alabama at Birmingham), Michael R. Green(Harvard University)

Molecular Cancer Therapeutics

October 27, 2009

10.1158/1535-7163.mct-09-0470

Cited by 46

Related Papers

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

|Blood|2010|1.3k

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

|Nature Medicine|2020|593

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

|Blood|2021|213

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

|Blood Advances|2020|195

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

|Cancer Discovery|2020|159